Advisors Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $41.1M | Buy |
474,386
+19,531
| +4% | +$1.87M | 0.48% | 68 |
|
|
2025
Q4 | $43.7M | Buy |
454,855
+19,479
| +4% | +$1.89M | 0.51% | 58 |
|
|
2025
Q3 | $41.5M | Buy |
435,376
+12,394
| +3% | +$1.14M | 0.51% | 55 |
|
|
2025
Q2 | $36.9M | Sell |
422,982
-84,713
| -17% | -$7.18M | 0.51% | 60 |
|
|
2025
Q1 | $45.6M | Buy |
507,695
+53,092
| +12% | +$4.75M | 0.71% | 44 |
|
|
2024
Q4 | $36.3M | Sell |
454,603
-134,476
| -23% | -$11.6M | 0.57% | 52 |
|
|
2024
Q3 | $53M | Sell |
589,079
-59,721
| -9% | -$5.02M | 0.86% | 28 |
|
|
2024
Q2 | $51.1M | Buy |
648,800
+35,596
| +6% | +$2.92M | 0.89% | 25 |
|
|
2024
Q1 | $53.4M | Buy |
613,204
+132,821
| +28% | +$11.3M | 0.98% | 22 |
|
|
2023
Q4 | $39.6M | Sell |
480,383
-63,693
| -12% | -$4.85M | 0.81% | 33 |
|
|
2023
Q3 | $42.6M | Sell |
544,076
-56,298
| -9% | -$4.71M | 1.08% | 22 |
|
|
2023
Q2 | $52.9M | Buy |
600,374
+23,889
| +4% | +$2.06M | 1.26% | 12 |
|
|
2023
Q1 | $46.5M | Buy |
576,485
+55,685
| +11% | +$4.54M | 1.2% | 12 |
|
|
2022
Q4 | $40.5M | Sell |
520,800
-6,301
| -1% | -$511K | 1.1% | 23 |
|
|
2022
Q3 | $43.7M | Buy |
527,101
+29,660
| +6% | +$2.67M | 1.17% | 19 |
|
|
2022
Q2 | $44.6M | Sell |
497,441
-1,429
| -0.3% | -$145K | 1.36% | 13 |
|
|
2022
Q1 | $55.4M | Buy |
498,870
+29,547
| +6% | +$3.12M | 1.51% | 9 |
|
|
2021
Q4 | $48.6M | Buy |
469,323
+26,984
| +6% | +$3.12M | 1.32% | 9 |
|
|
2021
Q3 | $55.4M | Buy |
442,339
+20,264
| +5% | +$2.62M | 1.69% | 6 |
|
|
2021
Q2 | $52.4M | Buy |
422,075
+8,448
| +2% | +$1.06M | 1.66% | 6 |
|
|
2021
Q1 | $48.9M | Buy |
413,627
+28,991
| +8% | +$3.4M | 1.71% | 6 |
|
|
2020
Q4 | $45.1M | Buy |
384,636
+14,622
| +4% | +$1.61M | 1.72% | 5 |
|
|
2020
Q3 | $38.5M | Buy |
370,014
+9,810
| +3% | +$985K | 1.79% | 6 |
|
|
2020
Q2 | $33M | Buy |
360,204
+49,777
| +16% | +$4.77M | 1.64% | 8 |
|
|
2020
Q1 | $28M | Buy |
310,427
+29,079
| +10% | +$3.09M | 1.78% | 7 |
|
|
2019
Q4 | $31.9M | Buy |
281,348
+11,492
| +4% | +$1.26M | 1.49% | 11 |
|
|
2019
Q3 | $29.3M | Buy |
269,856
+8,726
| +3% | +$910K | 1.59% | 11 |
|
|
2019
Q2 | $25.4M | Buy |
261,130
+22,272
| +9% | +$2.03M | 1.51% | 9 |
|
|
2019
Q1 | $21.7M | Buy |
238,858
+39,102
| +20% | +$3.5M | 1.35% | 9 |
|
|
2018
Q4 | $18.2M | Buy |
199,756
+16,338
| +9% | +$1.53M | 1.32% | 9 |
|
|
2018
Q3 | $18M | Buy |
183,418
+6,504
| +4% | +$601K | 1.18% | 20 |
|
|
2018
Q2 | $15.1M | Buy |
176,914
+17,399
| +11% | +$1.45M | 1.04% | 31 |
|
|
2018
Q1 | $12.8M | Buy |
159,515
+23,992
| +18% | +$1.98M | 0.97% | 39 |
|
|
2017
Q4 | $10.9M | Buy |
135,523
+16,015
| +13% | +$1.28M | 0.87% | 45 |
|
|
2017
Q3 | $9.29M | Buy |
119,508
+15,740
| +15% | +$1.31M | 0.75% | 55 |
|
|
2017
Q2 | $9.21M | Buy |
103,768
+9,054
| +10% | +$763K | 0.75% | 54 |
|
|
2017
Q1 | $7.63M | Buy |
94,714
+4,772
| +5% | +$373K | 0.66% | 59 |
|
|
2016
Q4 | $6.41M | Buy |
89,942
+5,437
| +6% | +$427K | 0.61% | 63 |
|
|
2016
Q3 | $7.3M | Sell |
84,505
-1,404
| -2% | -$122K | 0.71% | 56 |
|
|
2016
Q2 | $7.45M | Buy |
85,909
+6,856
| +9% | +$554K | 0.76% | 48 |
|
|
2016
Q1 | $5.93M | Buy |
79,053
+24,547
| +45% | +$1.85M | 0.6% | 59 |
|
|
2015
Q4 | $4.19M | Buy |
54,506
+3,611
| +7% | +$272K | 0.42% | 75 |
|
|
2015
Q3 | $3.41M | Buy |
50,895
+6,163
| +14% | +$454K | 0.37% | 89 |
|
|
2015
Q2 | $3.31M | Buy |
44,732
+1,672
| +4% | +$128K | 0.36% | 91 |
|
|
2015
Q1 | $3.36M | Buy |
43,060
+4,984
| +13% | +$378K | 0.38% | 93 |
|
|
2014
Q4 | $2.75M | Buy |
38,076
+14,305
| +60% | +$994K | 0.33% | 95 |
|
|
2014
Q3 | $1.47M | Buy |
+23,771
| New | +$1.51M | 0.19% | 122 |
|
Other funds holding MDT
VCM
VPM
Advisors Capital Management's MDT Position: Q1 2026 in Review
Advisors Capital Management increased its Medtronic (MDT) stake by 4.3% in Q1 2026, buying an estimated $1.87M and bringing the position to 474,386 shares worth $41.1M. The position accounts for 0.48% of the portfolio, ranked #68.
Advisors Capital Management first reported a position in MDT in Q3 2014 and has held it in 47 quarters since. The position peaked at $55.4M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Advisors Capital Management held 474,386 shares of Medtronic worth $41.1M as of Q1 2026.
- Advisors Capital Management bought 19,531 Medtronic shares in Q1 2026, an estimated $1.87M.
- Medtronic made up 0.48% of Advisors Capital Management's portfolio in Q1 2026, its #68 holding.
- Advisors Capital Management first reported a position in Medtronic in Q3 2014 and has held it in 47 quarters since.
- Advisors Capital Management's Medtronic position peaked at $55.4M in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Advisors Capital Management's 13F filing for Q1 2026, filed 1 May 2026.